Bailard’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,800
| Closed | -$430K | – | 704 |
|
|
2021
Q2 | $430K | Sell |
6,800
-6,000
| -47% | -$379K | 0.01% | 433 |
|
|
2021
Q1 | $549K | Sell |
12,800
-1,200
| -9% | -$51.5K | 0.02% | 373 |
|
|
2020
Q4 | $801K | Sell |
14,000
-2,900
| -17% | -$166K | 0.04% | 240 |
|
|
2020
Q3 | $510K | Hold |
16,900
| – | – | 0.03% | 280 |
|
|
2020
Q2 | $552K | Buy |
16,900
+5,000
| +42% | +$163K | 0.03% | 258 |
|
|
2020
Q1 | $319K | Buy |
11,900
+900
| +8% | +$24.1K | 0.02% | 305 |
|
|
2019
Q4 | $337K | Sell |
11,000
-4,000
| -27% | -$123K | 0.02% | 383 |
|
|
2019
Q3 | $361K | Hold |
15,000
| – | – | 0.02% | 360 |
|
|
2019
Q2 | $380K | Buy |
15,000
+2,000
| +15% | +$50.7K | 0.02% | 355 |
|
|
2019
Q1 | $254K | Buy |
+13,000
| New | +$254K | 0.02% | 450 |
|